GlaxoSmithKline is a giant within the world’s pharmaceutical
industry. At their Evreux site in France, 1 300 people are working
with production and sales of medicines. In 1999 the laboratory
introduced the first anti-flu treatment. “In today’s competitive
situation, we cannot afford to make mistakes, neither when
developing products, nor when choosing production methods”, says M.
Le Furaut, Plant and Equipment Manager at GlaxoSmithKline. Extremely small available space The products mentioned have no equivalents on the market.
The 150 meters of transport length dedicated to this product have
been divided into three different lines. The main problem when
designing these lines is the very small space available. Jacques
Giroud, FlexLink’s Sales Area Manager, decided on a very compact
system with conveyor bends limited to 150 mm, a plastic chain
conveyor adaptable to the customers different types of
packages. Guaranteeing personnel safety There are practically no openings between the chain links
so that there are no risks of the products transported on the chain
being jammed and this also guarantees the security of the people
working on the line. “This was another criterion which was crucial
when choosing a partner for this installation”, says M. Le Furaut.
“Moreover the esthetical look of the FlexLink installation was
perfectly integrated into our environment.” No need for maintenance
“The FlexLink conveyors handling the new product have been running
for more than a year without any maintenance problems, apart from
one punctual response which gave us an opportunity to judge the
quality of the after sales service”, says M. Le Furant. “We had one
problem with jamming of products on the line during transport. M.
Giroud suggested that we should incorporate an upper guide which,
when placed on the chain solved the problem within 15
hours.” “The flexibility of the FlexLink components and the
possibilities for integrating the chain with the existing machines
has strengthened our choice. It is functioning just as we expected
with the new lines, and at the same time we could reuse the modules
we already had.” |